Apixaban prevents thromboembolic recurrences in cancer patients even at half the dose – Deutsches Ärzteblatt

Paris – Oral anticoagulation, which is currently typically administered with direct oral anticoagulants in cancer patients after a venous thromboembolism, can be continued at a reduced dose after the first six months. This is shown by the results of a non-inferiority study presented at the annual meeting of the American College of Cardiology...